Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, any gender
- People whose general health and ability to carry out daily activities falls within an acceptable range (scored 0–2 on a standard oncology scale), with a life expectancy of more than 3 months
- People who have been diagnosed with stomach cancer that has spread to other parts of the body or to nearby tissues, confirmed by a laboratory test of cells or tissue
- People whose recent blood and organ function test results (taken within 7 days before screening) meet specific minimum levels for white blood cells, platelets, haemoglobin, liver enzymes, protein, and kidney function (confirm exact values with the trial site)
- People who have at least one measurable area of cancer that can be tracked on scans, as assessed using standard medical criteria
- People who have not yet received chemotherapy for advanced disease, and who are planned to receive a first course of treatment combining immunotherapy (one of several approved medicines, chosen by the treating doctor) with chemotherapy (one of several approved combinations, chosen by the treating doctor)
- People (or their legal representative or guardian) who are willing to sign a consent form confirming they understand the study and agree to take part
Who may not be able to join:
- Women who are pregnant or breastfeeding, or women of childbearing age who have not used adequate contraception
- People who have had another type of cancer in the past 5 years, except for certain previously cured skin cancers or cervical pre-cancers
- People who have a brain tumour or cancer that has spread to the brain and is not currently under control, or who have significant pressure in the skull or neurological or psychiatric symptoms
- People with serious or uncontrolled heart conditions — including heart attack, heart failure, unstable chest pain, significant fluid around the heart, or unstable heart rhythm — occurring within the 6 months before joining
- People with serious neurological or psychiatric conditions such as dementia or epilepsy
- People with severe or uncontrolled infections, or serious blood clotting problems, or a clear tendency to bleed
- People with significant damage to major organs
- People with a build-up of fluid around the lungs or in the abdomen that is causing breathing difficulty rated at a certain level of severity, and that requires direct local treatment
- People who have been taking probiotics or antibiotics on a long-term basis
- People whom the trial investigator considers unsuitable for the trial for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The gut microbiota predicts progression-free survival (PFS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.